Editas Medicine, Inc.EDITNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank83
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-638.03%
Historical baseline
PeriodValueYoY Change
TTM0.00%+100.0%
2024-721.39%-245.5%
2023-208.80%+81.3%
2022-1114.11%-51.3%
2021-736.35%-410.5%
2020-144.25%+78.6%
2019-672.60%-94.4%
2018-345.91%+59.3%
2017-849.82%+46.5%
2016-1587.11%-